King's Health Partners

London

0 studies enrolling now · 1 studies all time

What they study most

AML

Studies at this site

• Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML) — Stopped early